{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:59:56Z","timestamp":1760057996910,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jemermed.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:50:40Z","timestamp":1616784640000},"page":"e67-e70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Guillain-Barr\u00e9 Syndrome after Novel Coronavirus Disease 2019"],"prefix":"10.1016","volume":"61","author":[{"given":"Jordan","family":"Yakoby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Litvak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2021.03.022_bib0001","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: new infection, old complication?","volume":"267","author":"Padroni","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"GBS-Consensus Group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome","volume":"45","author":"van der Mech\u00e9","year":"2001","journal-title":"Eur Neurol"},{"issue":"9","key":"10.1016\/j.jemermed.2021.03.022_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007695","article-title":"Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barr\u00e9 syndrome in Brazil","volume":"13","author":"Rivera-Correa","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0005","article-title":"A case series of Guillain-Barr\u00e9 syndrome following Covid-19 infection in New York","author":"Chan","year":"2020","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0006","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain-Barre syndrome: incidence and mortality rates in US hospitals","volume":"70","author":"Alshekhlee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0007","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0008","first-page":"234","article-title":"Antiglycolipid antibodies in Guillain-Barr\u00e9 syndrome and autoimmune neuropathies","volume":"319","author":"Kusunoki","year":"2000","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.jemermed.2021.03.022_bib0009","first-page":"e4625","article-title":"Role of anti-ganglioside antibodies in the diagnosis of Guillain-Barr\u00e9 syndrome as an alternate investigation","volume":"11","author":"Saeed","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jemermed.2021.03.022_bib0011","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646792100305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646792100305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:42Z","timestamp":1760028522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073646792100305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S073646792100305X"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.03.022","relation":{},"ISSN":["0736-4679"],"issn-type":[{"type":"print","value":"0736-4679"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain-Barr\u00e9 Syndrome after Novel Coronavirus Disease 2019","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}